DPP4 and Sjogren syndrome: Studies conducted by Garreto and colleagues [84] demonstrated that in the saliva of patients suffering from Sjögren’s syndrome, there is a significant increase in both the activity and concentration of dipeptidyl peptidase-4 (DPP4/CD26).